A citation-based method for searching scientific literature

Eric Pujade-Lauraine, Felix Hilpert, Béatrice Weber, Alexander Reuss, Andres Poveda, Gunnar Kristensen, Roberto Sorio, Ignace Vergote, Petronella Witteveen, Aristotelis Bamias, Deolinda Pereira, Pauline Wimberger, Ana Oaknin, Mansoor Raza Mirza, Philippe Follana, David Bollag, Isabelle Ray-Coquard. J Clin Oncol 2014
Times Cited: 844



Susan M Domchek, Carol Aghajanian, Ronnie Shapira-Frommer, Rita K Schmutzler, M William Audeh, Michael Friedlander, Judith Balmaña, Gillian Mitchell, Georgeta Fried, Salomon M Stemmer, Ayala Hubert, Ora Rosengarten, Niklas Loman, Jane D Robertson, Helen Mann, Bella Kaufman. Gynecol Oncol 2016
Times Cited: 175




List of shared articles



Times cited

Platinum rechallenge treatment using gemcitabine plus carboplatin with or without bevacizumab for platinum-resistant ovarian cancer.
Hiroki Nasu, Shin Nishio, Jongmyung Park, Teruyuki Yoshimitsu, Ken Matsukuma, Kazuto Tasaki, Takahiro Katsuda, Atsumu Terada, Naotake Tsuda, Kimio Ushijima. Int J Clin Oncol 2022
0

Chronic stress induces platinum and Niraparib resistance in mouse models of ovarian cancer.
Mu Liu, Xiaofang Zhou, Lijuan Sun, Shanmei Tan, Tingting Liu, Wangli Xiao, Jie Tang. Exp Cell Res 2022
0

Therapeutic strategies to overcome cisplatin resistance in ovarian cancer.
Mengdi Song, Mingxiao Cui, Kehai Liu. Eur J Med Chem 2022
1

Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trial.
Jung-Yun Lee, Byoung-Gie Kim, Jae-Weon Kim, Jung Bok Lee, Eunhyang Park, Je-Gun Joung, Sunghoon Kim, Chel Hun Choi, Hee Seung Kim. J Gynecol Oncol 2022
0

The Budget Impact of Including Rucaparib on a US Payer Formulary for the Treatment of Patients with Metastatic Ovarian Cancer.
Katrine Wallace, Kelly Adamski, Ashwini Pai, Darya Rose, Anita Chawla. Pharmacoeconomics 2021
1

PARP Inhibitor in Platinum-Resistant Ovarian Cancer: Single-Center Real-World Experience.
Amit Agarwal, Saphalta Baghmar, Chandragouda Dodagoudar, Suhail Qureshi, Aseem Khurana, Vikas Vaibhav, Guresh Kumar. JCO Glob Oncol 2021
2

PARP-inhibitors in epithelial ovarian cancer: Actual positioning and future expectations.
Hélène Vanacker, Philipp Harter, Sana Intidhar Labidi-Galy, Susana Banerjee, Ana Oaknin, Domenica Lorusso, Isabelle Ray-Coquard. Cancer Treat Rev 2021
5